Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Results of a prospective phase II trial with oral low-dose bexarotene plus photochemotherapy (PUVA) in refractory and/or relapsed patients with mycosis fungoides.

Rupoli S, Canafoglia L, Goteri G, Leoni P, Brandozzi G, Federici I, Micucci G, Giantomassi F, Mozzicafreddo G, Alterini R, Filosa G, Ricotti G, Simonacci M, Scortechini AR, Zizzi A, Pimpinelli N.

Eur J Dermatol. 2016 Jan-Feb;26(1):13-20. doi: 10.1684/ejd.2015.2672.

PMID:
26678311
2.

Romiplostim before splenectomy in a patient with aggressive non-Hodgkin lymphoma and poor response to platelet transfusions.

Baldini S, Carrai V, Puccini B, Rigacci L, Alterini R, Bosi A.

Transfus Med. 2014 Apr;24(2):125-6. doi: 10.1111/tme.12106. Epub 2014 Feb 7. No abstract available.

PMID:
24720383
3.

Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas.

Fabbri A, Cencini E, Alterini R, Rubegni P, Rigacci L, Delfino C, Puccini B, Fimiani M, Bosi A, Bocchia M, Pimpinelli N; Gruppo Italiano Linfomi Cutanei (GILC).

Eur J Haematol. 2014 Aug;93(2):129-36. doi: 10.1111/ejh.12315. Epub 2014 Apr 4.

PMID:
24635751
4.

Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation.

Carrai V, Donnini I, Mazzanti B, Alterini R, Amato MP, Barilaro A, Bosi A, Massacesi L, Portaccio E, Repice AM, Rotunno G, Saccardi R.

Clin Neurol Neurosurg. 2013 Jul;115(7):1044-8. doi: 10.1016/j.clineuro.2012.10.032. Epub 2012 Dec 5.

PMID:
23218837
5.

Indolent cutaneous B-cell lymphoma: diagnosis and treatment 2012.

Santucci M, Grandi V, Maio V, Delfino C, Alterini R, Pimpinelli N.

G Ital Dermatol Venereol. 2012 Dec;147(6):581-8.

PMID:
23149704
6.

Combination treatment in CTCL: the current role of bexarotene.

Delfino C, Grandi V, Pileri A, Rupoli S, Quaglino P, Alterini R, Goteri G, Canafoglia L, Pimpinelli N.

G Ital Dermatol Venereol. 2012 Dec;147(6):573-80.

PMID:
23149703
7.

Drug-specific Th2 cells and IgE antibodies in a patient with anaphylaxis to rituximab.

Vultaggio A, Matucci A, Nencini F, Pratesi S, Petroni G, Cammelli D, Alterini R, Rigacci L, Romagnani S, Maggi E.

Int Arch Allergy Immunol. 2012;159(3):321-6. doi: 10.1159/000336839. Epub 2012 Jun 22.

PMID:
22846615
8.

Patients with ≥ 20 × 10(9)/l platelets at baseline may have a prompt response to romiplostim during the early phase of treatment: an italian single-institution experience.

Baldini S, Rigacci L, Carrai V, Alterini R, Fjerza R, Bosi A.

Mediterr J Hematol Infect Dis. 2012;4(1):e2012044. doi: 10.4084/MJHID.2012.044. Epub 2012 Jun 28.

9.

Long-term follow-up of concomitant treatment with romiplostim and warfarin in a patient with immune thrombocytopenia and severe cardiac comorbidities.

Baldini S, Rigacci L, Carrai V, Fjerza R, Alterini R, Bosi A.

Platelets. 2013;24(3):242-3. doi: 10.3109/09537104.2012.686074. Epub 2012 May 30. No abstract available.

PMID:
22646237
10.

Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis.

Carrai V, Miniati I, Guiducci S, Capaccioli G, Alterini R, Saccardi R, Conforti ML, Rigacci L, Rotunno G, Bosi A, Cerinic MM.

Rheumatology (Oxford). 2012 Jun;51(6):1042-8. doi: 10.1093/rheumatology/ker447. Epub 2012 Jan 23.

PMID:
22271757
11.

Single dose palonosetron and dexamethasone in preventing nausea and vomiting induced by high emetogenic ABVD regimen in Hodgkin Lymphoma patients.

Rigacci L, Landi C, Caruso JP, Puccini B, Alterini R, Carrai V, Perrone T, Bosi A.

Leuk Res. 2012 Feb;36(2):182-5. doi: 10.1016/j.leukres.2011.06.025. Epub 2011 Jul 14.

12.

Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies.

Pulini S, Rupoli S, Goteri G, Pimpinelli N, Alterini R, Bettacchi A, Mulattieri S, Picardi P, Tassetti A, Scortechini AR, Fioritoni G, Leoni P.

Eur J Haematol. 2009 Mar;82(3):184-93. doi: 10.1111/j.1600-0609.2008.01197.x.

PMID:
19215609
13.

Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia.

Vannucchi AM, Antonioli E, Guglielmelli P, Pancrazzi A, Guerini V, Barosi G, Ruggeri M, Specchia G, Lo-Coco F, Delaini F, Villani L, Finotto S, Ammatuna E, Alterini R, Carrai V, Capaccioli G, Di Lollo S, Liso V, Rambaldi A, Bosi A, Barbui T.

Blood. 2008 Aug 1;112(3):844-7. doi: 10.1182/blood-2008-01-135897. Epub 2008 Jun 2.

PMID:
18519816
14.

A 48-year-old woman with dyspnoea on exertion, anemia and thrombocytopenia.

Del Pace S, Alderighi C, Rasoini R, Alterini R, Micheli S, Santoro G.

Intern Emerg Med. 2008 Mar;3(1):33-6. doi: 10.1007/s11739-008-0138-y. Epub 2008 Mar 7. No abstract available.

PMID:
18324360
15.
16.

Pegylated liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphomas.

Pulini S, Rupoli S, Goteri G, Pimpinelli N, Alterini R, Tassetti A, Scortechini AR, Offidani M, Mulattieri S, Stronati A, Brandozzi G, Giacchetti A, Mozzicafreddo G, Ricotti G, Filosa G, Bettacchi A, Simonacci M, Novelli N, Leoni P.

Haematologica. 2007 May;92(5):686-9.

17.

Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas.

Rigacci L, Nassi L, Puccioni M, Mappa S, Polito E, Dal Pozzo S, Alterini R, Carrai V, Puccini B, Bosi A.

Ann Hematol. 2007 Aug;86(8):565-8. Epub 2007 May 5.

PMID:
17483948
18.

Multispectral imaging autofluorescence microscopy in colonic and gastric cancer metastatic lymph nodes.

Pantalone D, Andreoli F, Fusi F, Basile V, Romano G, Giustozzi G, Rigacci L, Alterini R, Monici M.

Clin Gastroenterol Hepatol. 2007 Feb;5(2):230-6.

PMID:
17296531
19.

Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.

Zinzani PL, Quaglino P, Pimpinelli N, Berti E, Baliva G, Rupoli S, Martelli M, Alaibac M, Borroni G, Chimenti S, Alterini R, Alinari L, Fierro MT, Cappello N, Pileri A, Soligo D, Paulli M, Pileri S, Santucci M, Bernengo MG; Italian Study Group for Cutaneous Lymphomas.

J Clin Oncol. 2006 Mar 20;24(9):1376-82. Epub 2006 Feb 21.

PMID:
16492713
20.

Dose-dense CHOP plus rituximab (R-CHOP14) for the treatment of elderly patients with high-risk diffuse large B cell lymphoma: a pilot study.

Rigacci L, Nassi L, Alterini R, Carrai V, Longo G, Bernardi F, Martini V, Bosi A.

Acta Haematol. 2006;115(1-2):22-7.

PMID:
16424645
21.

18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results.

Rigacci L, Castagnoli A, Dini C, Carpaneto A, Matteini M, Alterini R, Carrai V, Nassi L, Bernardi F, Pieroni C, Bosi A.

Oncol Rep. 2005 Nov;14(5):1209-14.

PMID:
16211287
23.

The role of anthracyclines in combination chemotherapy for the treatment of follicular lymphoma: retrospective study of the Intergruppo Italiano Linfomi on 761 cases.

Rigacci L, Federico M, Martelli M, Zinzani PL, Cavanna L, Bellesi G, Merli F, Alterini R, Petrucci MT, Tani M, Liberati AM, Vitolo U, Pavone V, Cuneo A, Chisesib T, Brugiatelli M; Intergruppo Italiano Linfomi.

Leuk Lymphoma. 2003 Nov;44(11):1911-7.

PMID:
14738142
24.

Treatment of large cell lymphoma in elderly patients with a mitoxantrone, cyclophosphamide, etoposide, and prednisone regimen: long-term follow-up results.

Rigacci L, Carpaneto A, Alterini R, Carrai V, Bernardi F, Bellesi G, Longo G, Bosi A, Rossi Ferrini P.

Cancer. 2003 Jan 1;97(1):97-104. Review.

25.

The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hospital.

Cellai E, Magrini SM, Masala G, Alterini R, Costantini AS, Rigacci L, Olmastroni L, Papi MG, Spediacci MA, Innocenti F, Bellesi G, Ferrini PR, Biti G.

Int J Radiat Oncol Biol Phys. 2001 Apr 1;49(5):1327-37.

PMID:
11286841
26.

Multispectral imaging autofluorescence microscopy for the analysis of lymph-node tissues.

Rigacci L, Alterini R, Bernabei PA, Ferrini PR, Agati G, Fusi F, Monici M.

Photochem Photobiol. 2000 Jun;71(6):737-42.

PMID:
10857370
27.

Treatment of large cell lymphoma with the Fi2 regimen (doxorubicin, vincristine, cyclophosphamide, bleomycin and prednisone): 25-year experience.

Bellesi G, Rigacci L, Longo G, Alterini R, Bernardi F, Messori A, Trippoli S, Vaiani M, Carrai V, Rossi Ferrini P.

Oncol Rep. 2000 Jul-Aug;7(4):891-6.

PMID:
10854565
28.

Immunohistochemistry applied to the study of bone marrow Gaucher's cells: a case report.

Alterini R, Rigacci L, Stefanacci S, Innocenti F, Santini V, Carrai V, Rossi Ferrini P.

Eur J Histochem. 1999;43(3):235-9.

PMID:
10563256
29.

Induction of apoptosis by monosaccharide butyrate stable derivatives in chronic lymphocytic leukemia cells.

Santini V, Gozzini A, Scappini B, Caporale R, Zoccolante A, Rigacci L, Gelardi E, Grossi A, Alterini R, Ferrini PR.

Haematologica. 1999 Oct;84(10):897-904.

30.

Unusual bone marrow metastases in a breast cancer patient.

Alterini R, Rigacci L, Carrai V.

Haematologica. 1998 Dec;83(12):1120-1. No abstract available.

31.

Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA.

Vannucchi AM, Bosi A, Glinz S, Pacini P, Linari S, Saccardi R, Alterini R, Rigacci L, Guidi S, Lombardini L, Longo G, Mariani MP, Rossi-Ferrini P.

Br J Haematol. 1998 Dec;103(3):610-7.

PMID:
9858208
32.

Treatments for newly diagnosed multiple myeloma: analysis of survival data and cost-effectiveness evaluation.

Trippoli S, Messori A, Becagli P, Alterini R, Tendi E.

Oncol Rep. 1998 Nov-Dec;5(6):1475-82.

PMID:
9769391
33.

Second bone marrow transplantation in non-Hodgkin's lymphoma.

Messori A, Costantini M, Bonistalli L, Alterini R.

J Clin Oncol. 1998 Feb;16(2):804-6. No abstract available.

PMID:
9469378
34.

Cost-effectiveness of autologous bone marrow transplantation in patients with relapsed non-Hodgkin's lymphoma.

Messori A, Bonistalli L, Costantini M, Alterini R.

Bone Marrow Transplant. 1997 Feb;19(3):275-81.

35.

Pseudo-Gaucher cells in the bone marrow of a patient with centrocytic nodular non-Hodgkin's lymphoma.

Alterini R, Rigacci L, Stefanacci S.

Haematologica. 1996 May-Jun;81(3):282-3. No abstract available.

36.

A new protocol (MiCEP) for the treatment of intermediate or high-grade non-Hodgkin's lymphoma in the elderly.

Bellesi G, Rigacci L, Alterini R, Bernardi F, Stefanacci S, Innocenti F, Fusco II, Longo G, Di Lollo S, Ferrini PR.

Leuk Lymphoma. 1996 Feb;20(5-6):475-80.

PMID:
8833406
37.

In vivo administration of stem cell factor enhances both proliferation and maturation of murine megakaryocytes.

Grossi A, Vannucchi AM, Bacci P, Longo G, Rafanelli D, Alterini R, Rossi Ferrini P.

Haematologica. 1995 Jan-Feb;80(1):18-24.

38.

Combined surgery and chemotherapy in primary gastric non-Hodgkin's lymphoma: a retrospective study in sixty-six patients.

Rigacci L, Bellesi G, Alterini R, Bernardi F, Di Lollo S, Ferrini PR.

Leuk Lymphoma. 1994 Aug;14(5-6):483-9.

PMID:
7812209
39.

Human bone marrow non-B, non-T cells produce interleukin 4 in response to cross-linkage of Fc epsilon and Fc gamma receptors.

Piccinni MP, Macchia D, Parronchi P, Giudizi MG, Bani D, Alterini R, Grossi A, Ricci M, Maggi E, Romagnani S.

Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8656-60.

40.

Impaired erythropoietin production in mice treated with cyclosporin A.

Vannucchi AM, Grossi A, Bosi A, Rafanelli D, Guidi S, Saccardi R, Alterini R, Ferrini PR.

Blood. 1991 Sep 15;78(6):1615-8.

PMID:
1884028
41.

Combined surgery and chemotherapy for the treatment of primary gastrointestinal intermediate- or high-grade non-Hodgkin's lymphomas.

Bellesi G, Alterini R, Messori A, Bosi A, Bernardi F, di Lollo S, Ferrini PR.

Br J Cancer. 1989 Aug;60(2):244-8.

Supplemental Content

Loading ...
Support Center